As of Feb 17
| +0.31 / +0.57%|
The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 56.50, with a high estimate of 68.00 and a low estimate of 42.00. The median estimate represents a +3.50% increase from the last price of 54.59.
The current consensus among 24 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.